Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Profit After Tax (2021 - 2026)

Cingulate's (CINGW) quarterly Profit After Tax came in at -$5.9 million in Q2 2026, down 17.8% on a YoY basis from -$7.1 million in Q2 2025, and up 6.42% quarter-over-quarter from -$6.3 million in Q4 2025.

Analysis

Cingulate (CINGW) Profit After Tax (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Profit After Tax for 6 consecutive years, with -$5.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Profit After Tax fell 17.8% year-over-year to -$5.9 million; the trailing twelve-month figure through Jun 2026 stood at -$24.5 million (down 27.48% YoY), and the FY2025 full-year result was -$22.4 million, down 35.57% from the prior year.
  • Profit After Tax rose to -$5.9 million in Q2 2026 per CINGW's latest filing, from -$6.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$3.0 million in Q1 2024 and bottomed at -$7.3 million in Q3 2025.
  • Historically, Profit After Tax has averaged -$5.1 million across 5 years, with a median of -$5.0 million in 2025.
  • The widest YoY moves for Profit After Tax: up 73.66% in 2022, down 275.1% in 2022.
  • Over 5 years, Profit After Tax stood at -$4.6 million in 2022, then slumped by 50.6% to -$6.9 million in 2023, then gained by 10.15% to -$6.2 million in 2024, then dropped by 0.67% to -$6.3 million in 2025, then increased by 6.42% to -$5.9 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$5.9 million, -$6.3 million, and -$7.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn 5.53 Bn
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn 3.62 Bn
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 3.26 Bn
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn -248.00 Mn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn 438.21 Mn
7 Revolution Medicines 44.21 Bn 44.21 Bn - -644.37 Mn
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn 333.00 Mn
10 Cingulate 100,214.03 100,214.03 - -5.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.87 Mn
Dec 31, 2025 -6.27 Mn
Sep 30, 2025 -7.34 Mn
Jun 30, 2025 -4.98 Mn
Mar 31, 2025 -3.85 Mn
Dec 31, 2024 -6.23 Mn
Sep 30, 2024 -4.13 Mn
Jun 30, 2024 -3.23 Mn
Mar 31, 2024 -2.97 Mn
Dec 31, 2023 -6.93 Mn
Sep 30, 2023 -5.98 Mn
Jun 30, 2023 -6.62 Mn
Mar 31, 2023 -4.00 Mn
Dec 31, 2022 -4.60 Mn
Sep 30, 2022 -4.03 Mn
Jun 30, 2022 -4.04 Mn
Mar 31, 2022 -5.00 Mn
Dec 31, 2021 -2.65 Mn
Sep 30, 2021 -15.29 Mn
Jun 30, 2021 -1.43 Mn